First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued

First Tracks Biotherapeutics, Inc. is a clinical-stage biotechnology company that develops antibody therapeutics designed to modulate immune pathways involved in autoimmune and inflammatory diseases. The company was formerly known as Biopharma Co., Inc. and changed its name to First Tracks Biotherapeutics, Inc. in February 2026. Incorporated in 2025, it is headquartered in San Diego, California, and operates as a subsidiary of AnaptysBio, Inc.